Alcohol-related liver disease phenotype impacts survival after an acute variceal bleeding episode
- PMID: 37183551
- DOI: 10.1111/liv.15606
Alcohol-related liver disease phenotype impacts survival after an acute variceal bleeding episode
Abstract
Background & aims: Alcohol-related hepatitis (AH) encompasses a high mortality. AH might be a concomitant event in patients with acute variceal bleeding (AVB). The current study aimed to assess the prevalence of AH in patients with AVB and to compare the clinical outcomes of AH patients to other alcohol-related liver disease (ALD) phenotypes and viral cirrhosis.
Methods: Multicentre, observational study including 916 patients with AVB falling under the next categories: AH (n = 99), ALD cirrhosis actively drinking (d-ALD) (n = 285), ALD cirrhosis abstinent from alcohol (a-ALD) (n = 227) and viral cirrhosis (n = 305). We used a Cox proportional hazards model to calculate adjusted hazard ratio (HR) of death adjusted by MELD.
Results: The prevalence of AH was 16% considering only ALD patients. AH patients exhibited more complications. Forty-two days transplant-free survival was worse among AH, but statistical differences were only observed between AH and d-ALD groups (84 vs. 93%; p = 0.005), when adjusted by MELD no differences were observed between AH and the other groups. At one-year, survival of AH patients (72.7%) was similar to the other groups; when adjusted by MELD mortality HR was better in AH compared to a-ALD (0.48; 0.29-0.8, p = 0.004). Finally, active drinkers who remained abstinent presented better survival, independently of having AH.
Conclusions: Contrary to expected, AH patients with AVB present no worse one-year survival than other patients with different alcohol-related phenotypes or viral cirrhosis. Abstinence influences long-term survival and could explain these counterintuitive results.
Keywords: abstinence; alcohol; alcohol-related hepatitis; cirrhosis; upper gastrointestinal bleeding.
© 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
References
REFERENCES
-
- WHO. World Health Organization. Global Status Report on Alcohol and Health. 2018. Accessed 2018. http://www.who.int/substance_abuse/publications/global_alcohol_report/en/
-
- Julien J, Ayer T, Bethea ED, Tapper EB, Chhatwal J. Projected prevalence and mortality associated with alcohol-related liver disease in the USA, 2019-40: a modelling study. Lancet Public Health. 2020;5(6):e316-e323.
-
- Crabb DW, Bataller R, Chalasani NP, et al. Standard definitions and common data elements for clinical trials in patients with alcoholic hepatitis: recommendation from the NIAAA alcoholic hepatitis consortia. Gastroenterology. 2016;150(4):785-790.
-
- EASL Clinical Practice Guidelines. Management of alcohol-related liver disease. J Hepatol. 2018;69(1):154-181.
-
- Rudler M, Mouri S, Charlotte F, et al. Prognosis of treated severe alcoholic hepatitis in patients with gastrointestinal bleeding. J Hepatol. 2015;62(4):816-821.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources